Commentary
Open Access
- 1 March 2005
- journal article
- for debate
- Published by Elsevier in International Psychogeriatrics
- Vol. 17 (1) , 22-29
- https://doi.org/10.1017/s1041610205241029
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2004
- Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugsAnnals of Neurology, 2003
- Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilitiesInternational Journal of Geriatric Psychiatry, 2002
- A double‐blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patientsInternational Journal of Geriatric Psychiatry, 2001
- Tolerability and effectiveness of atypical antipsychotics in male geriatric inpatientsInternational Journal of Geriatric Psychiatry, 2001
- Olanzapine Treatment of Psychotic and Behavioral Symptoms in Patients With Alzheimer Disease in Nursing Care FacilitiesArchives of General Psychiatry, 2000
- Control of aggression and agitation in patients with dementia: efficacy and safety of risperidoneInternational Journal of Geriatric Psychiatry, 2000
- A long-term, multicenter, open-label study of risperidone in elderly patients with psychosisInternational Journal of Geriatric Psychiatry, 2000
- Withdrawal of Haloperidol, Thioridazine, and Lorazepam in the Nursing HomeArchives of internal medicine (1960), 1999
- “Mini-mental state”Journal of Psychiatric Research, 1975